[1]
Haque, S., Shukla, A. and Kem, A. 2017. Treatment satisfaction and safety of sitagliptin versus pioglitazone in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. International Journal of Basic & Clinical Pharmacology. 6, 2 (Jan. 2017), 338–343. DOI:https://doi.org/10.18203/2319-2003.ijbcp20170326.